Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 2,416 | 3,392 | 2,530 | 1,815 | 19,100 |
| Gross Profit | 2,416 | 3,392 | 2,530 | 1,815 | 19,100 |
| Operating Expenses | 19,945 | 21,603 | 17,091 | 15,895 | 16,072 |
| Operating Income | -17,529 | -18,211 | -14,561 | -14,080 | 3,028 |
| Interest Expense | 103 | 95 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 22 | 57 | 11 |
| Pre-tax Income | -17,632 | -18,306 | -14,539 | -14,023 | 3,039 |
| Net Income Continuous | -17,632 | -18,306 | -14,539 | -14,023 | 3,039 |
| Net Income | $-17,632 | $-18,306 | $-14,539 | $-14,023 | $3,039 |
| EPS Basic Total Ops | -8.20 | -9.00 | -9.20 | -8.00 | 1.60 |
| EPS Basic Continuous Ops | -8.16 | -8.94 | -7.68 | -8.16 | 1.79 |
| EPS Diluted Total Ops | -8.20 | -9.00 | -9.20 | -8.00 | 1.60 |
| EPS Diluted Continuous Ops | -8.16 | -8.94 | -7.68 | -7.90 | 1.53 |
| EBITDA(a) | $-17,451 | $-18,137 | $-14,490 | $-15,715 | $3,112 |